nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenamide—CA9—breast cancer	0.547	1	CbGaD
Diclofenamide—CYP2C9—Anastrozole—breast cancer	0.0375	0.332	CbGbCtD
Diclofenamide—CYP2C9—Idarubicin—breast cancer	0.0284	0.251	CbGbCtD
Diclofenamide—CYP2C9—Capecitabine—breast cancer	0.0156	0.138	CbGbCtD
Diclofenamide—CYP2C9—Tamoxifen—breast cancer	0.0125	0.111	CbGbCtD
Diclofenamide—CYP2C9—Paclitaxel—breast cancer	0.00975	0.0863	CbGbCtD
Diclofenamide—CYP2C9—Fluorouracil—breast cancer	0.00923	0.0817	CbGbCtD
Diclofenamide—CA5A—female reproductive system—breast cancer	0.00213	0.0674	CbGeAlD
Diclofenamide—CA5B—mammary gland—breast cancer	0.002	0.0631	CbGeAlD
Diclofenamide—CA5A—endocrine gland—breast cancer	0.0018	0.057	CbGeAlD
Diclofenamide—CA9—female reproductive system—breast cancer	0.00124	0.0394	CbGeAlD
Diclofenamide—CA14—adrenal gland—breast cancer	0.00115	0.0364	CbGeAlD
Diclofenamide—CA4—nipple—breast cancer	0.00114	0.0361	CbGeAlD
Diclofenamide—CA9—endocrine gland—breast cancer	0.00105	0.0333	CbGeAlD
Diclofenamide—Hydrochlorothiazide—CA9—breast cancer	0.00103	0.529	CrCbGaD
Diclofenamide—CYP2C9—mammary gland—breast cancer	0.000967	0.0306	CbGeAlD
Diclofenamide—CA2—nipple—breast cancer	0.000945	0.0299	CbGeAlD
Diclofenamide—CA12—female reproductive system—breast cancer	0.000921	0.0291	CbGeAlD
Diclofenamide—Trichlormethiazide—CA9—breast cancer	0.000916	0.471	CrCbGaD
Diclofenamide—CA5B—adipose tissue—breast cancer	0.000899	0.0284	CbGeAlD
Diclofenamide—CA5B—female reproductive system—breast cancer	0.000826	0.0261	CbGeAlD
Diclofenamide—CA5B—adrenal gland—breast cancer	0.000806	0.0255	CbGeAlD
Diclofenamide—CA1—adipose tissue—breast cancer	0.000794	0.0251	CbGeAlD
Diclofenamide—CA2—embryo—breast cancer	0.00078	0.0247	CbGeAlD
Diclofenamide—CA12—endocrine gland—breast cancer	0.000779	0.0246	CbGeAlD
Diclofenamide—CA1—female reproductive system—breast cancer	0.00073	0.0231	CbGeAlD
Diclofenamide—CA5B—endocrine gland—breast cancer	0.000699	0.0221	CbGeAlD
Diclofenamide—CA1—bone marrow—breast cancer	0.000689	0.0218	CbGeAlD
Diclofenamide—CA2—epithelium—breast cancer	0.000636	0.0201	CbGeAlD
Diclofenamide—CA4—pituitary gland—breast cancer	0.000623	0.0197	CbGeAlD
Diclofenamide—CA4—adipose tissue—breast cancer	0.00062	0.0196	CbGeAlD
Diclofenamide—CA1—endocrine gland—breast cancer	0.000617	0.0195	CbGeAlD
Diclofenamide—CA2—skin of body—breast cancer	0.000605	0.0191	CbGeAlD
Diclofenamide—CA4—female reproductive system—breast cancer	0.00057	0.018	CbGeAlD
Diclofenamide—CA4—adrenal gland—breast cancer	0.000556	0.0176	CbGeAlD
Diclofenamide—CA4—bone marrow—breast cancer	0.000538	0.017	CbGeAlD
Diclofenamide—CA4—female gonad—breast cancer	0.000519	0.0164	CbGeAlD
Diclofenamide—CA2—pituitary gland—breast cancer	0.000516	0.0163	CbGeAlD
Diclofenamide—CA2—adipose tissue—breast cancer	0.000514	0.0163	CbGeAlD
Diclofenamide—CA5B—lymph node—breast cancer	0.000483	0.0153	CbGeAlD
Diclofenamide—CA4—endocrine gland—breast cancer	0.000483	0.0153	CbGeAlD
Diclofenamide—CA2—female reproductive system—breast cancer	0.000473	0.015	CbGeAlD
Diclofenamide—CA2—adrenal gland—breast cancer	0.000461	0.0146	CbGeAlD
Diclofenamide—CA2—bone marrow—breast cancer	0.000446	0.0141	CbGeAlD
Diclofenamide—CA2—female gonad—breast cancer	0.00043	0.0136	CbGeAlD
Diclofenamide—CA1—lymph node—breast cancer	0.000427	0.0135	CbGeAlD
Diclofenamide—CA2—endocrine gland—breast cancer	0.0004	0.0127	CbGeAlD
Diclofenamide—CYP2C9—female reproductive system—breast cancer	0.0004	0.0127	CbGeAlD
Diclofenamide—CYP2C9—endocrine gland—breast cancer	0.000339	0.0107	CbGeAlD
Diclofenamide—CA4—lymph node—breast cancer	0.000334	0.0105	CbGeAlD
Diclofenamide—CA2—lymph node—breast cancer	0.000277	0.00875	CbGeAlD
Diclofenamide—Constipation—Thiotepa—breast cancer	0.00024	0.00122	CcSEcCtD
Diclofenamide—Pruritus—Melphalan—breast cancer	0.000238	0.00121	CcSEcCtD
Diclofenamide—Tension—Paclitaxel—breast cancer	0.000238	0.00121	CcSEcCtD
Diclofenamide—Agranulocytosis—Capecitabine—breast cancer	0.000237	0.00121	CcSEcCtD
Diclofenamide—Thrombocytopenia—Irinotecan—breast cancer	0.000237	0.0012	CcSEcCtD
Diclofenamide—Thrombocytopenia—Mitoxantrone—breast cancer	0.000237	0.0012	CcSEcCtD
Diclofenamide—Hepatic failure—Doxorubicin—breast cancer	0.000237	0.0012	CcSEcCtD
Diclofenamide—Asthenia—Goserelin—breast cancer	0.000235	0.0012	CcSEcCtD
Diclofenamide—Nervousness—Paclitaxel—breast cancer	0.000235	0.00119	CcSEcCtD
Diclofenamide—Confusional state—Fluorouracil—breast cancer	0.000234	0.00119	CcSEcCtD
Diclofenamide—Dizziness—Vinblastine—breast cancer	0.000234	0.00119	CcSEcCtD
Diclofenamide—Body temperature increased—Vinorelbine—breast cancer	0.000232	0.00118	CcSEcCtD
Diclofenamide—Pruritus—Goserelin—breast cancer	0.000232	0.00118	CcSEcCtD
Diclofenamide—Feeling abnormal—Thiotepa—breast cancer	0.000231	0.00117	CcSEcCtD
Diclofenamide—Thrombocytopenia—Gemcitabine—breast cancer	0.000231	0.00117	CcSEcCtD
Diclofenamide—Anorexia—Irinotecan—breast cancer	0.000231	0.00117	CcSEcCtD
Diclofenamide—Anorexia—Mitoxantrone—breast cancer	0.000231	0.00117	CcSEcCtD
Diclofenamide—Ataxia—Methotrexate—breast cancer	0.000231	0.00117	CcSEcCtD
Diclofenamide—Nausea—Chlorambucil—breast cancer	0.000229	0.00116	CcSEcCtD
Diclofenamide—Thrombocytopenia—Fluorouracil—breast cancer	0.000227	0.00115	CcSEcCtD
Diclofenamide—Dizziness—Tamoxifen—breast cancer	0.000227	0.00115	CcSEcCtD
Diclofenamide—Tremor—Paclitaxel—breast cancer	0.000227	0.00115	CcSEcCtD
Diclofenamide—Anorexia—Gemcitabine—breast cancer	0.000225	0.00114	CcSEcCtD
Diclofenamide—Vomiting—Vinblastine—breast cancer	0.000225	0.00114	CcSEcCtD
Diclofenamide—Body temperature increased—Thiotepa—breast cancer	0.000222	0.00113	CcSEcCtD
Diclofenamide—Headache—Vinblastine—breast cancer	0.000222	0.00112	CcSEcCtD
Diclofenamide—Anorexia—Fluorouracil—breast cancer	0.000221	0.00112	CcSEcCtD
Diclofenamide—Vomiting—Tamoxifen—breast cancer	0.000218	0.00111	CcSEcCtD
Diclofenamide—Paraesthesia—Irinotecan—breast cancer	0.000218	0.0011	CcSEcCtD
Diclofenamide—Paraesthesia—Mitoxantrone—breast cancer	0.000218	0.0011	CcSEcCtD
Diclofenamide—Dizziness—Goserelin—breast cancer	0.000217	0.0011	CcSEcCtD
Diclofenamide—Leukopenia—Paclitaxel—breast cancer	0.000217	0.0011	CcSEcCtD
Diclofenamide—Rash—Tamoxifen—breast cancer	0.000217	0.0011	CcSEcCtD
Diclofenamide—Ataxia—Epirubicin—breast cancer	0.000216	0.0011	CcSEcCtD
Diclofenamide—Somnolence—Mitoxantrone—breast cancer	0.000216	0.00109	CcSEcCtD
Diclofenamide—Somnolence—Irinotecan—breast cancer	0.000216	0.00109	CcSEcCtD
Diclofenamide—Headache—Tamoxifen—breast cancer	0.000215	0.00109	CcSEcCtD
Diclofenamide—Vomiting—Melphalan—breast cancer	0.000214	0.00109	CcSEcCtD
Diclofenamide—Dyspepsia—Irinotecan—breast cancer	0.000213	0.00108	CcSEcCtD
Diclofenamide—Dyspepsia—Mitoxantrone—breast cancer	0.000213	0.00108	CcSEcCtD
Diclofenamide—Tinnitus—Capecitabine—breast cancer	0.000213	0.00108	CcSEcCtD
Diclofenamide—Rash—Melphalan—breast cancer	0.000212	0.00108	CcSEcCtD
Diclofenamide—Paraesthesia—Gemcitabine—breast cancer	0.000212	0.00108	CcSEcCtD
Diclofenamide—Asthenia—Vinorelbine—breast cancer	0.000211	0.00107	CcSEcCtD
Diclofenamide—Decreased appetite—Irinotecan—breast cancer	0.000211	0.00107	CcSEcCtD
Diclofenamide—Decreased appetite—Mitoxantrone—breast cancer	0.000211	0.00107	CcSEcCtD
Diclofenamide—Nausea—Vinblastine—breast cancer	0.00021	0.00107	CcSEcCtD
Diclofenamide—Somnolence—Gemcitabine—breast cancer	0.00021	0.00107	CcSEcCtD
Diclofenamide—Hypokalaemia—Epirubicin—breast cancer	0.000209	0.00106	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Irinotecan—breast cancer	0.000209	0.00106	CcSEcCtD
Diclofenamide—Fatigue—Mitoxantrone—breast cancer	0.000209	0.00106	CcSEcCtD
Diclofenamide—Fatigue—Irinotecan—breast cancer	0.000209	0.00106	CcSEcCtD
Diclofenamide—Vomiting—Goserelin—breast cancer	0.000209	0.00106	CcSEcCtD
Diclofenamide—Paraesthesia—Fluorouracil—breast cancer	0.000208	0.00106	CcSEcCtD
Diclofenamide—Pruritus—Vinorelbine—breast cancer	0.000208	0.00106	CcSEcCtD
Diclofenamide—Constipation—Mitoxantrone—breast cancer	0.000207	0.00105	CcSEcCtD
Diclofenamide—Constipation—Irinotecan—breast cancer	0.000207	0.00105	CcSEcCtD
Diclofenamide—Rash—Goserelin—breast cancer	0.000207	0.00105	CcSEcCtD
Diclofenamide—Somnolence—Fluorouracil—breast cancer	0.000206	0.00105	CcSEcCtD
Diclofenamide—Headache—Goserelin—breast cancer	0.000206	0.00104	CcSEcCtD
Diclofenamide—Decreased appetite—Gemcitabine—breast cancer	0.000205	0.00104	CcSEcCtD
Diclofenamide—Dyspepsia—Fluorouracil—breast cancer	0.000204	0.00104	CcSEcCtD
Diclofenamide—Nausea—Tamoxifen—breast cancer	0.000204	0.00104	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000204	0.00103	CcSEcCtD
Diclofenamide—Fatigue—Gemcitabine—breast cancer	0.000204	0.00103	CcSEcCtD
Diclofenamide—Constipation—Gemcitabine—breast cancer	0.000202	0.00103	CcSEcCtD
Diclofenamide—Decreased appetite—Fluorouracil—breast cancer	0.000202	0.00102	CcSEcCtD
Diclofenamide—Asthenia—Thiotepa—breast cancer	0.000201	0.00102	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Fluorouracil—breast cancer	0.0002	0.00102	CcSEcCtD
Diclofenamide—Ataxia—Doxorubicin—breast cancer	0.0002	0.00102	CcSEcCtD
Diclofenamide—Nausea—Melphalan—breast cancer	0.0002	0.00101	CcSEcCtD
Diclofenamide—Feeling abnormal—Irinotecan—breast cancer	0.0002	0.00101	CcSEcCtD
Diclofenamide—Feeling abnormal—Mitoxantrone—breast cancer	0.0002	0.00101	CcSEcCtD
Diclofenamide—Confusional state—Paclitaxel—breast cancer	0.000199	0.00101	CcSEcCtD
Diclofenamide—Pruritus—Thiotepa—breast cancer	0.000199	0.00101	CcSEcCtD
Diclofenamide—Nausea—Goserelin—breast cancer	0.000195	0.00099	CcSEcCtD
Diclofenamide—Feeling abnormal—Gemcitabine—breast cancer	0.000195	0.000988	CcSEcCtD
Diclofenamide—Dizziness—Vinorelbine—breast cancer	0.000194	0.000987	CcSEcCtD
Diclofenamide—Hypokalaemia—Doxorubicin—breast cancer	0.000194	0.000983	CcSEcCtD
Diclofenamide—Thrombocytopenia—Paclitaxel—breast cancer	0.000194	0.000983	CcSEcCtD
Diclofenamide—Body temperature increased—Irinotecan—breast cancer	0.000192	0.000973	CcSEcCtD
Diclofenamide—Body temperature increased—Mitoxantrone—breast cancer	0.000192	0.000973	CcSEcCtD
Diclofenamide—Feeling abnormal—Fluorouracil—breast cancer	0.000191	0.000971	CcSEcCtD
Diclofenamide—Drowsiness—Methotrexate—breast cancer	0.000189	0.000961	CcSEcCtD
Diclofenamide—Anorexia—Paclitaxel—breast cancer	0.000188	0.000957	CcSEcCtD
Diclofenamide—Vomiting—Vinorelbine—breast cancer	0.000187	0.000949	CcSEcCtD
Diclofenamide—Body temperature increased—Gemcitabine—breast cancer	0.000187	0.000948	CcSEcCtD
Diclofenamide—Tremor—Capecitabine—breast cancer	0.000186	0.000945	CcSEcCtD
Diclofenamide—Dizziness—Thiotepa—breast cancer	0.000186	0.000942	CcSEcCtD
Diclofenamide—Rash—Vinorelbine—breast cancer	0.000185	0.000941	CcSEcCtD
Diclofenamide—Headache—Vinorelbine—breast cancer	0.000184	0.000935	CcSEcCtD
Diclofenamide—Leukopenia—Docetaxel—breast cancer	0.000184	0.000933	CcSEcCtD
Diclofenamide—Pollakiuria—Epirubicin—breast cancer	0.000184	0.000932	CcSEcCtD
Diclofenamide—Body temperature increased—Fluorouracil—breast cancer	0.000184	0.000932	CcSEcCtD
Diclofenamide—Weight decreased—Epirubicin—breast cancer	0.00018	0.000913	CcSEcCtD
Diclofenamide—Vomiting—Thiotepa—breast cancer	0.000178	0.000906	CcSEcCtD
Diclofenamide—Leukopenia—Capecitabine—breast cancer	0.000178	0.000903	CcSEcCtD
Diclofenamide—Paraesthesia—Paclitaxel—breast cancer	0.000178	0.000901	CcSEcCtD
Diclofenamide—Drowsiness—Epirubicin—breast cancer	0.000177	0.0009	CcSEcCtD
Diclofenamide—Rash—Thiotepa—breast cancer	0.000177	0.000898	CcSEcCtD
Diclofenamide—Agranulocytosis—Methotrexate—breast cancer	0.000177	0.000897	CcSEcCtD
Diclofenamide—Headache—Thiotepa—breast cancer	0.000176	0.000893	CcSEcCtD
Diclofenamide—Somnolence—Paclitaxel—breast cancer	0.000176	0.000892	CcSEcCtD
Diclofenamide—Nausea—Vinorelbine—breast cancer	0.000175	0.000886	CcSEcCtD
Diclofenamide—Dyspepsia—Paclitaxel—breast cancer	0.000174	0.000883	CcSEcCtD
Diclofenamide—Asthenia—Mitoxantrone—breast cancer	0.000174	0.000883	CcSEcCtD
Diclofenamide—Asthenia—Irinotecan—breast cancer	0.000174	0.000883	CcSEcCtD
Diclofenamide—Decreased appetite—Paclitaxel—breast cancer	0.000172	0.000872	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000171	0.000866	CcSEcCtD
Diclofenamide—Fatigue—Paclitaxel—breast cancer	0.00017	0.000865	CcSEcCtD
Diclofenamide—Pollakiuria—Doxorubicin—breast cancer	0.00017	0.000862	CcSEcCtD
Diclofenamide—Asthenia—Gemcitabine—breast cancer	0.000169	0.00086	CcSEcCtD
Diclofenamide—Constipation—Paclitaxel—breast cancer	0.000169	0.000858	CcSEcCtD
Diclofenamide—Confusional state—Docetaxel—breast cancer	0.000169	0.000858	CcSEcCtD
Diclofenamide—Pruritus—Gemcitabine—breast cancer	0.000167	0.000848	CcSEcCtD
Diclofenamide—Nausea—Thiotepa—breast cancer	0.000167	0.000846	CcSEcCtD
Diclofenamide—Weight decreased—Doxorubicin—breast cancer	0.000166	0.000845	CcSEcCtD
Diclofenamide—Agranulocytosis—Epirubicin—breast cancer	0.000165	0.000839	CcSEcCtD
Diclofenamide—Pruritus—Fluorouracil—breast cancer	0.000164	0.000834	CcSEcCtD
Diclofenamide—Thrombocytopenia—Docetaxel—breast cancer	0.000164	0.000833	CcSEcCtD
Diclofenamide—Drowsiness—Doxorubicin—breast cancer	0.000164	0.000832	CcSEcCtD
Diclofenamide—Confusional state—Capecitabine—breast cancer	0.000164	0.00083	CcSEcCtD
Diclofenamide—Feeling abnormal—Paclitaxel—breast cancer	0.000163	0.000827	CcSEcCtD
Diclofenamide—Dizziness—Irinotecan—breast cancer	0.00016	0.000814	CcSEcCtD
Diclofenamide—Anorexia—Docetaxel—breast cancer	0.00016	0.000811	CcSEcCtD
Diclofenamide—Thrombocytopenia—Capecitabine—breast cancer	0.000159	0.000806	CcSEcCtD
Diclofenamide—Tinnitus—Methotrexate—breast cancer	0.000159	0.000805	CcSEcCtD
Diclofenamide—Body temperature increased—Paclitaxel—breast cancer	0.000156	0.000793	CcSEcCtD
Diclofenamide—Anorexia—Capecitabine—breast cancer	0.000155	0.000785	CcSEcCtD
Diclofenamide—Vomiting—Irinotecan—breast cancer	0.000154	0.000782	CcSEcCtD
Diclofenamide—Vomiting—Mitoxantrone—breast cancer	0.000154	0.000782	CcSEcCtD
Diclofenamide—Dizziness—Fluorouracil—breast cancer	0.000154	0.000779	CcSEcCtD
Diclofenamide—Agranulocytosis—Doxorubicin—breast cancer	0.000153	0.000777	CcSEcCtD
Diclofenamide—Rash—Mitoxantrone—breast cancer	0.000153	0.000776	CcSEcCtD
Diclofenamide—Rash—Irinotecan—breast cancer	0.000153	0.000776	CcSEcCtD
Diclofenamide—Headache—Mitoxantrone—breast cancer	0.000152	0.000771	CcSEcCtD
Diclofenamide—Headache—Irinotecan—breast cancer	0.000152	0.000771	CcSEcCtD
Diclofenamide—Paraesthesia—Docetaxel—breast cancer	0.00015	0.000764	CcSEcCtD
Diclofenamide—Vomiting—Gemcitabine—breast cancer	0.00015	0.000762	CcSEcCtD
Diclofenamide—Somnolence—Docetaxel—breast cancer	0.000149	0.000756	CcSEcCtD
Diclofenamide—Rash—Gemcitabine—breast cancer	0.000149	0.000756	CcSEcCtD
Diclofenamide—Tinnitus—Epirubicin—breast cancer	0.000148	0.000753	CcSEcCtD
Diclofenamide—Headache—Gemcitabine—breast cancer	0.000148	0.000751	CcSEcCtD
Diclofenamide—Vomiting—Fluorouracil—breast cancer	0.000148	0.000749	CcSEcCtD
Diclofenamide—Dyspepsia—Docetaxel—breast cancer	0.000148	0.000749	CcSEcCtD
Diclofenamide—Rash—Fluorouracil—breast cancer	0.000146	0.000743	CcSEcCtD
Diclofenamide—Paraesthesia—Capecitabine—breast cancer	0.000146	0.00074	CcSEcCtD
Diclofenamide—Decreased appetite—Docetaxel—breast cancer	0.000146	0.000739	CcSEcCtD
Diclofenamide—Headache—Fluorouracil—breast cancer	0.000145	0.000738	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Docetaxel—breast cancer	0.000145	0.000734	CcSEcCtD
Diclofenamide—Fatigue—Docetaxel—breast cancer	0.000144	0.000733	CcSEcCtD
Diclofenamide—Nausea—Irinotecan—breast cancer	0.000144	0.000731	CcSEcCtD
Diclofenamide—Nausea—Mitoxantrone—breast cancer	0.000144	0.000731	CcSEcCtD
Diclofenamide—Constipation—Docetaxel—breast cancer	0.000143	0.000727	CcSEcCtD
Diclofenamide—Dyspepsia—Capecitabine—breast cancer	0.000143	0.000725	CcSEcCtD
Diclofenamide—Asthenia—Paclitaxel—breast cancer	0.000142	0.00072	CcSEcCtD
Diclofenamide—Decreased appetite—Capecitabine—breast cancer	0.000141	0.000716	CcSEcCtD
Diclofenamide—Nausea—Gemcitabine—breast cancer	0.00014	0.000712	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Capecitabine—breast cancer	0.00014	0.000711	CcSEcCtD
Diclofenamide—Fatigue—Capecitabine—breast cancer	0.00014	0.00071	CcSEcCtD
Diclofenamide—Pruritus—Paclitaxel—breast cancer	0.00014	0.00071	CcSEcCtD
Diclofenamide—Constipation—Capecitabine—breast cancer	0.000139	0.000704	CcSEcCtD
Diclofenamide—Feeling abnormal—Docetaxel—breast cancer	0.000138	0.000701	CcSEcCtD
Diclofenamide—Nausea—Fluorouracil—breast cancer	0.000138	0.0007	CcSEcCtD
Diclofenamide—Tinnitus—Doxorubicin—breast cancer	0.000137	0.000697	CcSEcCtD
Diclofenamide—Tension—Epirubicin—breast cancer	0.000136	0.00069	CcSEcCtD
Diclofenamide—Nervousness—Epirubicin—breast cancer	0.000135	0.000683	CcSEcCtD
Diclofenamide—Feeling abnormal—Capecitabine—breast cancer	0.000134	0.000679	CcSEcCtD
Diclofenamide—Body temperature increased—Docetaxel—breast cancer	0.000132	0.000672	CcSEcCtD
Diclofenamide—Leukopenia—Methotrexate—breast cancer	0.000132	0.000672	CcSEcCtD
Diclofenamide—Dizziness—Paclitaxel—breast cancer	0.000131	0.000664	CcSEcCtD
Diclofenamide—Body temperature increased—Capecitabine—breast cancer	0.000128	0.000651	CcSEcCtD
Diclofenamide—Tension—Doxorubicin—breast cancer	0.000126	0.000638	CcSEcCtD
Diclofenamide—Vomiting—Paclitaxel—breast cancer	0.000126	0.000638	CcSEcCtD
Diclofenamide—Rash—Paclitaxel—breast cancer	0.000125	0.000633	CcSEcCtD
Diclofenamide—Nervousness—Doxorubicin—breast cancer	0.000124	0.000632	CcSEcCtD
Diclofenamide—Leukopenia—Epirubicin—breast cancer	0.000124	0.000629	CcSEcCtD
Diclofenamide—Headache—Paclitaxel—breast cancer	0.000124	0.000629	CcSEcCtD
Diclofenamide—Confusional state—Methotrexate—breast cancer	0.000122	0.000618	CcSEcCtD
Diclofenamide—Asthenia—Docetaxel—breast cancer	0.00012	0.00061	CcSEcCtD
Diclofenamide—Pruritus—Docetaxel—breast cancer	0.000119	0.000602	CcSEcCtD
Diclofenamide—Thrombocytopenia—Methotrexate—breast cancer	0.000118	0.0006	CcSEcCtD
Diclofenamide—Nausea—Paclitaxel—breast cancer	0.000117	0.000596	CcSEcCtD
Diclofenamide—Asthenia—Capecitabine—breast cancer	0.000116	0.000591	CcSEcCtD
Diclofenamide—Anorexia—Methotrexate—breast cancer	0.000115	0.000584	CcSEcCtD
Diclofenamide—Pruritus—Capecitabine—breast cancer	0.000115	0.000583	CcSEcCtD
Diclofenamide—Leukopenia—Doxorubicin—breast cancer	0.000115	0.000582	CcSEcCtD
Diclofenamide—Confusional state—Epirubicin—breast cancer	0.000114	0.000579	CcSEcCtD
Diclofenamide—Dizziness—Docetaxel—breast cancer	0.000111	0.000562	CcSEcCtD
Diclofenamide—Thrombocytopenia—Epirubicin—breast cancer	0.000111	0.000562	CcSEcCtD
Diclofenamide—Paraesthesia—Methotrexate—breast cancer	0.000108	0.000551	CcSEcCtD
Diclofenamide—Anorexia—Epirubicin—breast cancer	0.000108	0.000547	CcSEcCtD
Diclofenamide—Somnolence—Methotrexate—breast cancer	0.000107	0.000545	CcSEcCtD
Diclofenamide—Dizziness—Capecitabine—breast cancer	0.000107	0.000545	CcSEcCtD
Diclofenamide—Vomiting—Docetaxel—breast cancer	0.000107	0.000541	CcSEcCtD
Diclofenamide—Dyspepsia—Methotrexate—breast cancer	0.000106	0.00054	CcSEcCtD
Diclofenamide—Rash—Docetaxel—breast cancer	0.000106	0.000536	CcSEcCtD
Diclofenamide—Confusional state—Doxorubicin—breast cancer	0.000105	0.000535	CcSEcCtD
Diclofenamide—Decreased appetite—Methotrexate—breast cancer	0.000105	0.000533	CcSEcCtD
Diclofenamide—Headache—Docetaxel—breast cancer	0.000105	0.000533	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Methotrexate—breast cancer	0.000104	0.000529	CcSEcCtD
Diclofenamide—Fatigue—Methotrexate—breast cancer	0.000104	0.000529	CcSEcCtD
Diclofenamide—Vomiting—Capecitabine—breast cancer	0.000103	0.000524	CcSEcCtD
Diclofenamide—Thrombocytopenia—Doxorubicin—breast cancer	0.000102	0.00052	CcSEcCtD
Diclofenamide—Rash—Capecitabine—breast cancer	0.000102	0.000519	CcSEcCtD
Diclofenamide—Headache—Capecitabine—breast cancer	0.000102	0.000516	CcSEcCtD
Diclofenamide—Paraesthesia—Epirubicin—breast cancer	0.000101	0.000515	CcSEcCtD
Diclofenamide—Somnolence—Epirubicin—breast cancer	0.0001	0.00051	CcSEcCtD
Diclofenamide—Anorexia—Doxorubicin—breast cancer	9.97e-05	0.000506	CcSEcCtD
Diclofenamide—Nausea—Docetaxel—breast cancer	9.95e-05	0.000505	CcSEcCtD
Diclofenamide—Feeling abnormal—Methotrexate—breast cancer	9.95e-05	0.000505	CcSEcCtD
Diclofenamide—Dyspepsia—Epirubicin—breast cancer	9.95e-05	0.000505	CcSEcCtD
Diclofenamide—Decreased appetite—Epirubicin—breast cancer	9.83e-05	0.000499	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Epirubicin—breast cancer	9.76e-05	0.000495	CcSEcCtD
Diclofenamide—Fatigue—Epirubicin—breast cancer	9.74e-05	0.000495	CcSEcCtD
Diclofenamide—Constipation—Epirubicin—breast cancer	9.67e-05	0.000491	CcSEcCtD
Diclofenamide—Nausea—Capecitabine—breast cancer	9.64e-05	0.000489	CcSEcCtD
Diclofenamide—Body temperature increased—Methotrexate—breast cancer	9.55e-05	0.000485	CcSEcCtD
Diclofenamide—Paraesthesia—Doxorubicin—breast cancer	9.39e-05	0.000477	CcSEcCtD
Diclofenamide—Feeling abnormal—Epirubicin—breast cancer	9.31e-05	0.000473	CcSEcCtD
Diclofenamide—Somnolence—Doxorubicin—breast cancer	9.3e-05	0.000472	CcSEcCtD
Diclofenamide—Dyspepsia—Doxorubicin—breast cancer	9.21e-05	0.000467	CcSEcCtD
Diclofenamide—Decreased appetite—Doxorubicin—breast cancer	9.09e-05	0.000461	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Doxorubicin—breast cancer	9.03e-05	0.000458	CcSEcCtD
Diclofenamide—Fatigue—Doxorubicin—breast cancer	9.02e-05	0.000458	CcSEcCtD
Diclofenamide—Constipation—Doxorubicin—breast cancer	8.94e-05	0.000454	CcSEcCtD
Diclofenamide—Body temperature increased—Epirubicin—breast cancer	8.94e-05	0.000454	CcSEcCtD
Diclofenamide—Asthenia—Methotrexate—breast cancer	8.67e-05	0.00044	CcSEcCtD
Diclofenamide—Feeling abnormal—Doxorubicin—breast cancer	8.62e-05	0.000437	CcSEcCtD
Diclofenamide—Pruritus—Methotrexate—breast cancer	8.55e-05	0.000434	CcSEcCtD
Diclofenamide—Body temperature increased—Doxorubicin—breast cancer	8.27e-05	0.00042	CcSEcCtD
Diclofenamide—Asthenia—Epirubicin—breast cancer	8.11e-05	0.000412	CcSEcCtD
Diclofenamide—Pruritus—Epirubicin—breast cancer	8e-05	0.000406	CcSEcCtD
Diclofenamide—Dizziness—Methotrexate—breast cancer	7.99e-05	0.000405	CcSEcCtD
Diclofenamide—Vomiting—Methotrexate—breast cancer	7.68e-05	0.00039	CcSEcCtD
Diclofenamide—Rash—Methotrexate—breast cancer	7.62e-05	0.000387	CcSEcCtD
Diclofenamide—Headache—Methotrexate—breast cancer	7.57e-05	0.000384	CcSEcCtD
Diclofenamide—Asthenia—Doxorubicin—breast cancer	7.5e-05	0.000381	CcSEcCtD
Diclofenamide—Dizziness—Epirubicin—breast cancer	7.47e-05	0.000379	CcSEcCtD
Diclofenamide—Pruritus—Doxorubicin—breast cancer	7.4e-05	0.000376	CcSEcCtD
Diclofenamide—Vomiting—Epirubicin—breast cancer	7.19e-05	0.000365	CcSEcCtD
Diclofenamide—Nausea—Methotrexate—breast cancer	7.17e-05	0.000364	CcSEcCtD
Diclofenamide—Rash—Epirubicin—breast cancer	7.13e-05	0.000362	CcSEcCtD
Diclofenamide—Headache—Epirubicin—breast cancer	7.08e-05	0.000359	CcSEcCtD
Diclofenamide—Dizziness—Doxorubicin—breast cancer	6.92e-05	0.000351	CcSEcCtD
Diclofenamide—Nausea—Epirubicin—breast cancer	6.71e-05	0.000341	CcSEcCtD
Diclofenamide—Vomiting—Doxorubicin—breast cancer	6.65e-05	0.000338	CcSEcCtD
Diclofenamide—Rash—Doxorubicin—breast cancer	6.59e-05	0.000335	CcSEcCtD
Diclofenamide—Headache—Doxorubicin—breast cancer	6.55e-05	0.000333	CcSEcCtD
Diclofenamide—Nausea—Doxorubicin—breast cancer	6.21e-05	0.000315	CcSEcCtD
Diclofenamide—CA1—Metabolism—COMT—breast cancer	2.37e-05	0.000217	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GSTP1—breast cancer	2.36e-05	0.000216	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—NCOR1—breast cancer	2.35e-05	0.000216	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GSTM1—breast cancer	2.35e-05	0.000216	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PLA2G4A—breast cancer	2.35e-05	0.000216	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—HSP90AA1—breast cancer	2.33e-05	0.000214	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—ABCB1—breast cancer	2.33e-05	0.000213	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—HMOX1—breast cancer	2.32e-05	0.000213	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—ITPR1—breast cancer	2.32e-05	0.000213	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX2—breast cancer	2.31e-05	0.000212	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PIK3CD—breast cancer	2.29e-05	0.00021	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—breast cancer	2.29e-05	0.00021	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—TYMS—breast cancer	2.28e-05	0.000209	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—NCOA1—breast cancer	2.27e-05	0.000208	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—ALB—breast cancer	2.26e-05	0.000207	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—NCOR1—breast cancer	2.26e-05	0.000207	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PLA2G4A—breast cancer	2.26e-05	0.000207	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GSTM1—breast cancer	2.26e-05	0.000207	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GPX1—breast cancer	2.26e-05	0.000207	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—STK11—breast cancer	2.24e-05	0.000205	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CYP19A1—breast cancer	2.24e-05	0.000205	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—breast cancer	2.23e-05	0.000205	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CYP1A1—breast cancer	2.23e-05	0.000205	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—ABCB1—breast cancer	2.23e-05	0.000204	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PIK3CD—breast cancer	2.23e-05	0.000204	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PIK3CD—breast cancer	2.23e-05	0.000204	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—ERCC2—breast cancer	2.21e-05	0.000203	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—ALB—breast cancer	2.2e-05	0.000202	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—ALB—breast cancer	2.2e-05	0.000202	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PIK3CG—breast cancer	2.19e-05	0.000201	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—TYMS—breast cancer	2.19e-05	0.000201	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SYNJ2—breast cancer	2.17e-05	0.000199	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PLA2G4A—breast cancer	2.16e-05	0.000199	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—NCOR1—breast cancer	2.16e-05	0.000199	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GSTM1—breast cancer	2.16e-05	0.000199	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GPX1—breast cancer	2.16e-05	0.000198	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—NOS3—breast cancer	2.16e-05	0.000198	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CYP1A1—breast cancer	2.14e-05	0.000196	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—ERCC2—breast cancer	2.12e-05	0.000195	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—NOS3—breast cancer	2.1e-05	0.000193	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—NOS3—breast cancer	2.1e-05	0.000193	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—MTHFR—breast cancer	2.08e-05	0.000191	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PIK3CD—breast cancer	2.08e-05	0.000191	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PIK3CD—breast cancer	2.08e-05	0.000191	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—COMT—breast cancer	2.08e-05	0.000191	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GPX1—breast cancer	2.07e-05	0.00019	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GSTP1—breast cancer	2.07e-05	0.00019	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—ALB—breast cancer	2.05e-05	0.000188	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—ALB—breast cancer	2.05e-05	0.000188	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CYP1A1—breast cancer	2.05e-05	0.000188	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—HMOX1—breast cancer	2.04e-05	0.000187	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ITPR1—breast cancer	2.04e-05	0.000187	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—ERCC2—breast cancer	2.04e-05	0.000187	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NDUFS3—breast cancer	2.01e-05	0.000185	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—MTHFR—breast cancer	2e-05	0.000183	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PIK3CB—breast cancer	1.99e-05	0.000183	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PTGS2—breast cancer	1.98e-05	0.000181	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—NOS3—breast cancer	1.96e-05	0.00018	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—NOS3—breast cancer	1.96e-05	0.00018	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ABCB1—breast cancer	1.96e-05	0.00018	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PIK3CB—breast cancer	1.94e-05	0.000178	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PIK3CB—breast cancer	1.94e-05	0.000178	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—MED12—breast cancer	1.94e-05	0.000178	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PIK3CD—breast cancer	1.93e-05	0.000177	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—TYMS—breast cancer	1.93e-05	0.000177	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PTGS2—breast cancer	1.92e-05	0.000177	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PTGS2—breast cancer	1.92e-05	0.000177	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CAV1—breast cancer	1.92e-05	0.000176	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—MTHFR—breast cancer	1.91e-05	0.000175	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—NCOR1—breast cancer	1.9e-05	0.000175	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GSTM1—breast cancer	1.9e-05	0.000175	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PLA2G4A—breast cancer	1.9e-05	0.000175	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—ALB—breast cancer	1.9e-05	0.000175	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CHST9—breast cancer	1.89e-05	0.000174	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	1.85e-05	0.00017	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CAV1—breast cancer	1.84e-05	0.000169	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GPX1—breast cancer	1.82e-05	0.000167	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—NOS3—breast cancer	1.82e-05	0.000167	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PIK3CB—breast cancer	1.81e-05	0.000166	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PIK3CB—breast cancer	1.81e-05	0.000166	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CYP1A1—breast cancer	1.8e-05	0.000165	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	1.8e-05	0.000165	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PTGS2—breast cancer	1.8e-05	0.000165	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PTGS2—breast cancer	1.8e-05	0.000165	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—COX11—breast cancer	1.79e-05	0.000165	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ERCC2—breast cancer	1.79e-05	0.000164	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	1.77e-05	0.000162	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CAV1—breast cancer	1.76e-05	0.000162	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PIK3CG—breast cancer	1.75e-05	0.00016	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PTEN—breast cancer	1.72e-05	0.000158	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—breast cancer	1.71e-05	0.000157	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—MTHFR—breast cancer	1.68e-05	0.000154	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PIK3CB—breast cancer	1.68e-05	0.000154	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PTEN—breast cancer	1.68e-05	0.000154	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PTEN—breast cancer	1.68e-05	0.000154	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PIK3CG—breast cancer	1.68e-05	0.000154	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PTGS2—breast cancer	1.66e-05	0.000153	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SHMT1—breast cancer	1.64e-05	0.000151	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CDA—breast cancer	1.64e-05	0.000151	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	1.62e-05	0.000149	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PIK3CG—breast cancer	1.61e-05	0.000147	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	1.6e-05	0.000147	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC2A5—breast cancer	1.58e-05	0.000145	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLCO1B1—breast cancer	1.58e-05	0.000145	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PTEN—breast cancer	1.57e-05	0.000144	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PTEN—breast cancer	1.57e-05	0.000144	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CAV1—breast cancer	1.55e-05	0.000142	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	1.54e-05	0.000142	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PIK3CD—breast cancer	1.54e-05	0.000141	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—APRT—breast cancer	1.53e-05	0.00014	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—ALB—breast cancer	1.52e-05	0.000139	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—FASN—breast cancer	1.5e-05	0.000137	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—breast cancer	1.49e-05	0.000137	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PIK3CD—breast cancer	1.47e-05	0.000135	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—ALB—breast cancer	1.45e-05	0.000133	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PTEN—breast cancer	1.45e-05	0.000133	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—NOS3—breast cancer	1.45e-05	0.000133	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ANGPTL4—breast cancer	1.43e-05	0.000132	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ESRRA—breast cancer	1.43e-05	0.000132	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PIK3CG—breast cancer	1.41e-05	0.00013	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PIK3CD—breast cancer	1.41e-05	0.00013	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—ALB—breast cancer	1.39e-05	0.000128	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—NOS3—breast cancer	1.39e-05	0.000128	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	1.36e-05	0.000125	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HADHB—breast cancer	1.36e-05	0.000125	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GPI—breast cancer	1.36e-05	0.000125	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PIK3CB—breast cancer	1.34e-05	0.000123	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—NOS3—breast cancer	1.33e-05	0.000122	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PTGS2—breast cancer	1.33e-05	0.000122	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.3e-05	0.000119	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ALDH7A1—breast cancer	1.3e-05	0.000119	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ALDH1A1—breast cancer	1.3e-05	0.000119	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PIK3CB—breast cancer	1.28e-05	0.000118	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	1.28e-05	0.000118	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PTGS2—breast cancer	1.27e-05	0.000117	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—UMPS—breast cancer	1.24e-05	0.000114	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PHGDH—breast cancer	1.24e-05	0.000114	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ADSL—breast cancer	1.24e-05	0.000114	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NME1—breast cancer	1.24e-05	0.000114	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—FHL2—breast cancer	1.24e-05	0.000114	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PIK3CD—breast cancer	1.24e-05	0.000114	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PIK3CB—breast cancer	1.23e-05	0.000113	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ALB—breast cancer	1.23e-05	0.000112	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PTGS2—breast cancer	1.22e-05	0.000112	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—LDHB—breast cancer	1.22e-05	0.000112	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HPSE—breast cancer	1.22e-05	0.000112	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—BRIP1—breast cancer	1.22e-05	0.000112	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PIK3CA—breast cancer	1.22e-05	0.000111	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PIK3CA—breast cancer	1.18e-05	0.000109	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PIK3CA—breast cancer	1.18e-05	0.000109	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—NOS3—breast cancer	1.17e-05	0.000108	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PTEN—breast cancer	1.16e-05	0.000106	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HMMR—breast cancer	1.16e-05	0.000106	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTA3—breast cancer	1.16e-05	0.000106	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ABCC1—breast cancer	1.16e-05	0.000106	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PPARGC1B—breast cancer	1.12e-05	0.000103	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PTEN—breast cancer	1.11e-05	0.000102	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PIK3CA—breast cancer	1.11e-05	0.000101	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PIK3CA—breast cancer	1.11e-05	0.000101	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.09e-05	0.0001	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.09e-05	0.0001	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PIK3CB—breast cancer	1.08e-05	9.93e-05	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PTGS2—breast cancer	1.07e-05	9.84e-05	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PTEN—breast cancer	1.06e-05	9.76e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CA9—breast cancer	1.06e-05	9.7e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTA4—breast cancer	1.06e-05	9.7e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.04e-05	9.58e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.03e-05	9.48e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GPX2—breast cancer	1.03e-05	9.45e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTA2—breast cancer	1.03e-05	9.45e-05	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PIK3CA—breast cancer	1.02e-05	9.39e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GPX4—breast cancer	1.02e-05	9.34e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SULT1A1—breast cancer	1.02e-05	9.34e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTA1—breast cancer	9.95e-06	9.12e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—IDH1—breast cancer	9.95e-06	9.12e-05	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—AKT1—breast cancer	9.93e-06	9.1e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NAT2—breast cancer	9.83e-06	9.02e-05	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—AKT1—breast cancer	9.67e-06	8.87e-05	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—AKT1—breast cancer	9.67e-06	8.87e-05	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PTEN—breast cancer	9.36e-06	8.58e-05	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—AKT1—breast cancer	9.03e-06	8.28e-05	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—AKT1—breast cancer	9.03e-06	8.28e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	8.89e-06	8.15e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—DPYD—breast cancer	8.62e-06	7.91e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—MED12—breast cancer	8.62e-06	7.91e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ALDOA—breast cancer	8.49e-06	7.79e-05	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—AKT1—breast cancer	8.37e-06	7.67e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NCOA3—breast cancer	8.24e-06	7.56e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC2A2—breast cancer	8.18e-06	7.5e-05	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PIK3CA—breast cancer	8.17e-06	7.49e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	8.1e-06	7.43e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—MTR—breast cancer	8.02e-06	7.35e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CPT1A—breast cancer	8.02e-06	7.35e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ABCG2—breast cancer	8.02e-06	7.35e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HPGDS—breast cancer	7.86e-06	7.21e-05	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PIK3CA—breast cancer	7.83e-06	7.18e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HBA1—breast cancer	7.81e-06	7.17e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTT1—breast cancer	7.63e-06	6.99e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ACHE—breast cancer	7.63e-06	6.99e-05	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PIK3CA—breast cancer	7.51e-06	6.89e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP17A1—breast cancer	7.22e-06	6.62e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ENO1—breast cancer	7.15e-06	6.55e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PTGS1—breast cancer	7.15e-06	6.55e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	7.12e-06	6.53e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	7.03e-06	6.45e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP2D6—breast cancer	7.01e-06	6.43e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NCOA2—breast cancer	6.88e-06	6.31e-05	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—AKT1—breast cancer	6.67e-06	6.12e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—FASN—breast cancer	6.67e-06	6.12e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—BCHE—breast cancer	6.64e-06	6.09e-05	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PIK3CA—breast cancer	6.6e-06	6.05e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC5A5—breast cancer	6.56e-06	6.02e-05	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—AKT1—breast cancer	6.4e-06	5.87e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC2A1—breast cancer	6.34e-06	5.81e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NQO1—breast cancer	6.34e-06	5.81e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.21e-06	5.69e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP3A4—breast cancer	6.18e-06	5.67e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	6.15e-06	5.64e-05	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—AKT1—breast cancer	6.13e-06	5.62e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP1B1—breast cancer	6.08e-06	5.57e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HSP90AA1—breast cancer	5.96e-06	5.46e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NCOA1—breast cancer	5.8e-06	5.32e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP19A1—breast cancer	5.71e-06	5.24e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—STK11—breast cancer	5.71e-06	5.24e-05	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—AKT1—breast cancer	5.39e-06	4.94e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.36e-06	4.92e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—COMT—breast cancer	5.31e-06	4.87e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTP1—breast cancer	5.29e-06	4.85e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HMOX1—breast cancer	5.21e-06	4.78e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ITPR1—breast cancer	5.2e-06	4.77e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ABCB1—breast cancer	5e-06	4.59e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—TYMS—breast cancer	4.91e-06	4.51e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NCOR1—breast cancer	4.86e-06	4.45e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PLA2G4A—breast cancer	4.86e-06	4.45e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTM1—breast cancer	4.86e-06	4.45e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GPX1—breast cancer	4.65e-06	4.27e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP1A1—breast cancer	4.6e-06	4.22e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ERCC2—breast cancer	4.57e-06	4.19e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—MTHFR—breast cancer	4.29e-06	3.94e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CAV1—breast cancer	3.96e-06	3.63e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.78e-06	3.47e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PIK3CG—breast cancer	3.61e-06	3.31e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PIK3CD—breast cancer	3.17e-06	2.91e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ALB—breast cancer	3.13e-06	2.87e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NOS3—breast cancer	2.99e-06	2.75e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PIK3CB—breast cancer	2.76e-06	2.53e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PTGS2—breast cancer	2.74e-06	2.51e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PTEN—breast cancer	2.39e-06	2.19e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PIK3CA—breast cancer	1.68e-06	1.55e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—AKT1—breast cancer	1.38e-06	1.26e-05	CbGpPWpGaD
